Analyst initiations: GMTN, LEVP, ITMN, AET and MHS
Posted Sep 27th 2007 11:10AM by Eric Buscemi
Filed under: Analyst reports, Aetna Inc (AET), Analyst initiations
.gif)
MOST NOTEWORTHY: Gander Mountain, Lev Pharmaceuticals, Intermune, Aetna and Medco Health were today's noteworthy initiations:
- Nollenberger initiated shares of Gander Mountain Company (NASDAQ: GMTN) with a Sell rating and $5.00 target, and believes the company's goal of reaching profitability in 2007 could prove overly optimistic.
- Lev Pharmaceuticals (OTC: LEVP) was initiated with a Sector Outperformer rating and $3 target at CIBC, as the firm believes Cinryze will likely be approved in 1Q08 and they expect the company to have significant pricing leverage.
- JP Morgan resumed coverage of Intermune Inc (NASDAQ: ITMN) with an Overweight rating and expects shares to be driven by the company's pipeline in IPF and HCV.
- Aetna Incorporated (NYSE: AET) was initiated with an Outperform rating at Wachovia. The firm feels Aetna is positioned for better growth and higher quality earnings than its peers.
- William Blair started shares of Medco Health Solutions Inc (NYSE: MHS) with an Outperform rating, as they believe an aging population, rising health care costs, and an acceleration in new product introductions should increase demand for PBM services over the next five years.
OTHER INITIATIONS:
Tags: Advanced Semi, AdvancedSemi, AET, Aetna, ASX, Gander Mountain, GanderMountain, GMTN, initiation, initiations, Intermune, ITMN, Lev, Lev Pharmaceuticals, LEVP, LevPharmaceuticals, Medco Health, MedcoHealth, SIGM, Sigma Designs, SigmaDesigns, Silicon Image, SiliconImage, Siliconware Precision, SiliconwarePrecision, SIMG, SIRF, Sirf Technology, SirfTechnology, SPIL
Twitter finally reveals revenue ambition, wants to be Google -- but not yet
Google says: Chrome for Christmas
Why is gold marching higher? Ask the central bankers
